DailyIQ
|
Sector:HealthcareAll sectors
Last updated 4 minutes ago

A·Agilent Technologies, Inc.

$.
-. (-.%)
High
$127.96
Open
$126.69
Market Cap
35.89B
52W High
$160.27
Low
$126.35
P. Close
$126.90
P/E
25.38
52W Low
$108.35
Fwd P/E
19.23
DailyIQ Est.
$172.65
Technical Score (1D)
86
BUY
News Sentiment
55
BULLISH
Options market data shows a 30 % surge in call volume for Agilent Technologies, indicating a shift in trader sentiment toward a potential upside. The accompanying 15 % rise in implied volatility further signals that market participants are pricing in a significant move ahead of the company’s earnings release next month. This heightened activity suggests that the next 1–10 trading days could see increased volatility as traders position for the earnings announcement. The spike in bullish options activity also reflects broader biotech sector momentum, which could amplify Agilent’s price swings if the sector rallies. Traders should monitor the earnings guidance issued in the next few days, as any upside surprise could validate the options market’s expectations. Watch for any regulatory filings or product announcements that could provide additional catalysts or dampen the anticipated rally. If the earnings report confirms strong revenue growth, the implied volatility may compress, potentially leading to a sharp price move. Conversely, a miss on key metrics could trigger a rapid reversal, so keep an eye on the earnings call transcript for any sign of uncertainty. In the short term, the combination of increased call volume and rising implied volatility signals a heightened risk‑reward profile that traders should incorporate into their short‑term positioning.
Earnings Summary
Agilent Technologies is a global provider of application‑focused solutions for the life sciences, diagnostics, and applied chemical markets, operating through Life Sciences and Diagnostics, CrossLab, and Applied Markets segments that supply advanced instrumentation, services, and consumables to research and clinical laboratories. In the healthcare diagnostics and research sector, Agilent has maintained a strong operating margin and robust cash generation, positioning it as a quality‑growth play. In the most recent quarter, Q2 2026, the company reported EPS of $1.49 versus an estimate of $1.44, a beat, and revenue of $1.835 billion versus an estimate of $1.834 billion, also a beat; this contrasts with Q1 2026, where EPS of $1.36 fell short of the $1.396 estimate and revenue of $1.798 billion missed the $1.842 billion estimate, reflecting a dip after a period of growth. Over the past two fiscal years, Agilent’s revenue rose from $1.668 billion in Q1 2025 to $1.861 billion in Q3 2025, then fell to $1.798 billion in Q1 2026 before recovering to $1.835 billion in Q2 2026, indicating a modest YoY decline in early 2026 followed by a rebound; EPS peaked in Q3 2025 at $1.59, dipped in Q1 2026, and rebounded in Q2 2026, with the company achieving three consecutive earnings beats before the miss and subsequent beat. Recent news highlights Madison Investments’ continued stake amid AI‑related market uncertainty, Agilent’s AI partnership with OpenAI and BCG, and guidance upgrades to $7.39‑$7.49 billion for 2026, while speculation over a potential QIAGEN acquisition has weighed on sentiment; the company also cleared a quality screen with a 31.9% ROIC and high operating margin. Investors should watch for updates on the QIAGEN acquisition timeline, the rollout of the OpenAI/BCG AI partnership, and Q3 2026 earnings to confirm guidance and gauge the pace of AI integration and margin improvement.

EPS

EstBeatMiss
$1.22$1.32$1.43$1.53$1.64Q1'25Q2'25Q3'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.49 - -
Q2'26$1.44$1.49+3.8%
Q1'26$1.40$1.36-2.6%
Q3'25$1.58$1.59+0.4%
Q2'25$1.37$1.37+0.2%
Q1'25$1.26$1.31+3.6%

Revenue

EstBeatMiss
$1.6B$1.7B$1.8B$1.8B$1.9BQ1'25Q2'25Q3'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.9B - -
Q2'26$1.8B$1.8B+0.0%
Q1'26$1.8B$1.8B-2.4%
Q3'25 - $1.9B -
Q2'25 - $1.7B -
Q1'25 - $1.7B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

A Stock Snapshot

A is currently trading at $126.49, giving Agilent Technologies, Inc. a market cap of 35.89B and a P/E ratio of 25.4. Today's range spans $126.35–$127.96, with shares opening at $126.69 and moving down $0.41 (0.3%) from the prior close. DailyIQ's technical score sits at 86/100 (BUY) with a news sentiment reading of 55/100.

Over the past year A has traded between $108.35 and $160.27 - the current price is +16.7% off the 52-week low and -21.1% from the high. 30 analysts cover the stock with a Buy consensus and a mean 12-month target of $160.35 (range $144.00–$185.00), implying upside of +26.8%.

A is showing the kind of bullish setup that active managers add to on dips - 86/100 (BUY), neutral sentiment at 55/100, 35.89B market cap in Healthcare, price $126.49 (in the lower half of its 52-week range). The current P/E ratio stands at 25.4. At this cap tier, the combination of technical confirmation and positive sentiment is what separates speculative bullish positions from high-conviction ones. Annual range: $108.35–$160.27. The setup is in the latter category.

The combination of a BUY signal (86/100) and neutral news sentiment (55/100) puts A on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 35.89B in Healthcare market cap without immediately moving the stock. At $126.49 (in the lower half of its 52-week range in the $108.35–$160.27 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.